Clinical trial
RWE Study Utilizing the Cala Trio Device in Patients With Essential Tremor
NCT05540626 · Cala Health, Inc., Industry · Completed
Key facts
| NCT number | NCT05540626 |
|---|---|
| Title | RWE Study Utilizing the Cala Trio Device in Patients With Essential Tremor |
| Official title | Real World Evidence Study Utilizing the Cala Trio Device in Patients With Essential Tremor |
| Lead sponsor | Cala Health, Inc., Industry |
| Collaborators | CVS Healthspire Life Sciences Solutions |
| Status | Completed |
| Study type | Interventional |
| Conditions | Essential Tremor |
| Intervention type | Device |
| Interventions | Cala Trio |
| Enrollment | 276 |
| Start date | Apr 8, 2021 |
| Primary completion | Mar 1, 2024 |
| Completion | Mar 1, 2024 |
| First posted | Sep 14, 2022 |
| Last update posted | May 7, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: